Abstract
Introduction: Spasticity is a major problem in multiple sclerosis (MS) patients directly affecting their quality of life. Despite having many treatment modalities, the clinical effectiveness of these modalities is at best modest. Aim of the Study: The aim of this study was to test the effectiveness of repetitive peripheral magnetic stimulation (rpms) in decreasing spasticity and painful cramps in the lower extremities of MS patients. A secondary objective was to know whether this postulated improvement would result in an increase in the speed of walking of these patients. Patients and Methods: Twenty six MS cases were randomly assigned either to 6 sessions of active 1 Hz rpms over the paravertebral region bilaterally (Group 1; n=18) or to sham stimulation (Group 2; n=8). Outcome measures included the Modified Ashworth Scale (MAS) for spasticity, self-reported spasm frequency and degree of pain associated with it, generalized body pains and 25 feet walking test. All measures were examined at baseline, after the end of treatment, and 2 and 4 weeks later. EDSS of all study patients did not exceed 6.5. Results: There was no significant difference between the two studied groups at baseline. There was a significant difference between the two study groups in terms of muscle spasticity tested by MAS (p= 0.05), and spasm frequency and intensity (p<0.0001 for both). There was no significant difference between the two study groups in terms of duration taken to complete the 25 feet test or generalized body pain. There was no significant difference between relapsing remitting and secondary progressive MS cases receiving active stimulation. Conclusions: Rpms helps ameliorating MS related spasticity and muscle spasms. Further studies are needed to look into the effects of this improvement on the quality of life and the activities of daily living of those patients.
Highlights
Spasticity is a major problem in multiple sclerosis (MS) patients directly affecting their quality of life
There was a significant difference between the two study groups in terms of muscle spasticity tested by Modified Ashworth Scale (MAS) (p= 0.05), and spasm frequency and intensity (p
Further studies are needed to look into the effects of this improvement on the quality of life and the activities of daily living of those patients
Summary
Spasticity is a major problem in multiple sclerosis (MS) patients directly affecting their quality of life. Multiple sclerosis (MS) is the most common cause of physical disability in young adults [1]. There is a direct correlation between the severity of spasticity and the overall degree of disability and quality of life impairment [2]. Management of spasticity includes drug treatments [3], botulinum toxin injection for focal spasticity [4], and intrathecal baclofen [5]. Non pharmacological management is considered, and this includes physical therapy [6], transcutaneous electric nerve stimulation [7], and non-invasive brain stimulation [8]. Despite the abundance of modalities available for the management of MS related spasticity, there is limited evidence to the efficacy of any of them [10]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Physical Medicine & Rehabilitation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
